BioTE Holdings, LLC is a medical practice-building business within the hormone optimization space. BioTE Holdings, LLC, formerly known as Haymaker Acquisition Corp. III, is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $197.19M |
| Net Income (Most Recent Fiscal Year) | $3.16M |
| PE Ratio (Current Year Earnings Estimate) | 11.79 |
| PE Ratio (Trailing 12 Months) | 5.51 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.83 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 4.39 |
| Pre-Tax Margin (Trailing 12 Months) | 19.17% |
| Net Margin (Trailing 12 Months) | 15.73% |
| Return on Equity (Trailing 12 Months) | -21.00% |
| Return on Assets (Trailing 12 Months) | 18.26% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.98 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.74 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 3.94 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-1.59 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.10 |
| Earnings per Share (Most Recent Fiscal Year) | $0.71 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.90 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Common Shares Outstanding | 49.44M |
| Free Float | 37.57M |
| Market Capitalization | $166.11M |
| Average Volume (Last 20 Days) | 0.23M |
| Beta (Past 60 Months) | 1.21 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 24.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 21.68% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |